world
Eli Lilly CEO Seeks Agreement to Bring Mounjaro to Australia Amid Pricing Dispute
Despite multiple attempts, Eli Lilly has yet to reach a deal with Australia to list the diabetes and weight loss drug Mounjaro on the Pharmaceutical Benefits Scheme due to disagreements over pricing.
1 source Single-source report